Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $3.14 billion. The enterprise value is $2.45 billion.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 70.16 million shares outstanding. The number of shares has increased by 25.81% in one year.
| Current Share Class | 70.16M |
| Shares Outstanding | 70.16M |
| Shares Change (YoY) | +25.81% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 72.58% |
| Float | 45.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.86 |
| Forward PS | 51.38 |
| PB Ratio | 3.71 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 41.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.49, with a Debt / Equity ratio of 0.11.
| Current Ratio | 8.49 |
| Quick Ratio | 8.19 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,004.44 |
Financial Efficiency
Return on equity (ROE) is -32.17% and return on invested capital (ROIC) is -20.82%.
| Return on Equity (ROE) | -32.17% |
| Return on Assets (ROA) | -19.47% |
| Return on Invested Capital (ROIC) | -20.82% |
| Return on Capital Employed (ROCE) | -32.38% |
| Revenue Per Employee | $313,218 |
| Profits Per Employee | -$1.28M |
| Employee Count | 188 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.21% in the last 52 weeks. The beta is 2.19, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.19 |
| 52-Week Price Change | +48.21% |
| 50-Day Moving Average | 38.00 |
| 200-Day Moving Average | 39.44 |
| Relative Strength Index (RSI) | 58.44 |
| Average Volume (20 Days) | 933,254 |
Short Selling Information
The latest short interest is 7.58 million, so 10.81% of the outstanding shares have been sold short.
| Short Interest | 7.58M |
| Short Previous Month | 6.59M |
| Short % of Shares Out | 10.81% |
| Short % of Float | 16.54% |
| Short Ratio (days to cover) | 7.15 |
Income Statement
In the last 12 months, KYMR had revenue of $58.89 million and -$240.88 million in losses. Loss per share was -$3.11.
| Revenue | 58.89M |
| Gross Profit | -212.80M |
| Operating Income | -278.23M |
| Pretax Income | -157.85M |
| Net Income | -240.88M |
| EBITDA | -271.67M |
| EBIT | -278.23M |
| Loss Per Share | -$3.11 |
Full Income StatementBalance Sheet
The company has $463.15 million in cash and $86.33 million in debt, giving a net cash position of $689.16 million or $9.82 per share.
| Cash & Cash Equivalents | 463.15M |
| Total Debt | 86.33M |
| Net Cash | 689.16M |
| Net Cash Per Share | $9.82 |
| Equity (Book Value) | 786.23M |
| Book Value Per Share | 12.07 |
| Working Capital | 441.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$234.06 million and capital expenditures -$5.90 million, giving a free cash flow of -$239.96 million.
| Operating Cash Flow | -234.06M |
| Capital Expenditures | -5.90M |
| Free Cash Flow | -239.96M |
| FCF Per Share | -$3.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -472.50% |
| Pretax Margin | -409.07% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.81% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.66% |
| FCF Yield | -7.64% |
Dividend DetailsAnalyst Forecast
The average price target for KYMR is $58.94, which is 31.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $58.94 |
| Price Target Difference | 31.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 53.90% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 9.95 and a Piotroski F-Score of 1.
| Altman Z-Score | 9.95 |
| Piotroski F-Score | 1 |
